![]() |
BulkSupplements | Egg Whites International | A1Supplements.com | i-Supplements | Strength.com | VitaSprings | Myprotein | Beyondsupplements |
|
![]() |
|
Thread Tools | Search this Thread | Display Modes |
#1
|
||||
|
||||
![]()
Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab.
J Asthma. 2017 Dec 06;:1-6 Authors: Bulut I, Ozseker ZF, Coskun A, Serteser M, Unsal I Abstract BACKGROUND: Remodeling is a crucial feature of severe asthma and may be associated with activation of the allergic cascade by immunoglobulin E (IgE). Omalizumab, an anti-IgE monoclonal antibody, effectively targets the severe allergic asthma phenotype. Pregnancy-associated plasma protein-A (PAPP-A) is an insulin-like growth factor binding protein-4 (IGFBP-4) protease, increasing local insulin-like growth factor (IGF)-1 concentrations, which in turn initiating a cascade involved in the regulation of cell growth, differentiation, and proliferation in various tissues. In the present study, we evaluated the effects of omalizumab on serum PAPP-A, IGFBP-4, and IGF-1 levels in subjects with severe allergic asthma. METHODS: We studied 36 asthmatic subjects and 36 healthy controls. An ultrasensitive enzyme-linked immunosorbent assay (ELISA) kit was used to measure serum PAPP-A levels, and routine commercial ELISA kits were employed to assess serum levels of IGF-1, IGFBP-4 in control subjects and asthmatic subjects before therapy (baseline) and after six months of omalizumab therapy in patients with severe asthma. RESULTS: Compared to control subjects, serum PAPP-A and IGFB-4 levels were significantly higher in asthmatic subjects (both p values < 0.001). However, the serum IGF-I levels of asthmatic subjects were similar to those of control subjects (p > 0.05). In asthma subjects, 6-month omalizumab treatment significantly decreased the serum PAPP-A (p < 0.001), IGF-I (p = 0.031), and IGFB4 (p = 0.025) levels. CONCLUSION: PAPP-A level may be a useful biomarker for predicting airway remodeling in patients with severe asthma receiving omalizumab, and may also reflect the response to treatment. PMID: 29211611 [PubMed - as supplied by publisher] More... Insulin like growth factors IGF-1 Igf-1r3 This has been a World Class Bodybuilding automated thread
__________________
W C B B Affiliates PowderCity.com <---Best Selling Products BulkSupplements.com <---Save Money, Buy in BULK IslandSupplements.com <--- Latest Sale Items I-supplements.com <--- Vip Special Offers A1Supplements.com <----Clearance Supplements HideMyAss Security Proxy<---- Protect your online activity Home Chemistry Conversions <-- home chemistry needs Help WCBB by using our AMAZON.com link use for any amazon purchase. Egg Whites International <---100% Bio-Available Egg White Protein Liquid egg whites recipes ,-- protein shakes, smoothies, full delicious meals etc. Egg White Fitness Website <-- Site all about Egg Whites WorldClassBodyBuilding Teeshirts <-- get your WCBB t-shirts here, first design to latest |
![]() |
Bookmarks |
Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
Thread Tools | Search this Thread |
Display Modes | |
|
|